Brian Lian Viking Therapeutics, Inc. (VKTX) insider trading activity

VKTX Quotes by TradingView

Brian Lian is President & CEO of Viking Therapeutics, Inc.. Currently has a direct ownership of 2.3 Million shares of VKTX, which is worth approximately $109 Million. The most recent transaction as insider was on Sep 20, 2024, when has been sold 216,130 shares (Common stock, par value $0.00001 per share) at a price of $71.19 per share, resulting in proceeds of $15,386,294. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.3M
2.12% 3M change
4.87% 12M change
Total Value Held $109 Million

Brian Lian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2024
SELL
Open market or private sale
$15,386,294 $71.19 p/Share
216,130 Reduced 8.57%
2,304,927 Common stock, par valu...
Sep 20 2024
BUY
Exercise of conversion of derivative security
$1,290,830 $7.77 p/Share
166,130 Added 6.18%
2,521,057 Common stock, par valu...
Aug 21 2024
SELL
Open market or private sale
$69,900 $69.9 p/Share
1,000 Reduced 0.04%
2,354,927 Common stock, par valu...
Aug 21 2024
BUY
Exercise of conversion of derivative security
$7,770 $7.77 p/Share
1,000 Added 0.04%
2,355,927 Common stock, par valu...
Aug 19 2024
SELL
Open market or private sale
$7,479,894 $66.27 p/Share
112,870 Reduced 4.57%
2,354,927 Common stock, par valu...
Aug 19 2024
BUY
Exercise of conversion of derivative security
$876,999 $7.77 p/Share
112,870 Added 4.37%
2,467,797 Common stock, par valu...
Jul 30 2024
SELL
Open market or private sale
$6,702,443 $57.85 p/Share
115,859 Reduced 4.69%
2,354,927 Common stock, par valu...
Jul 29 2024
BUY
Grant, award, or other acquisition
-
204,333 Added 7.64%
2,470,786 Common stock, par valu...
Mar 27 2024
SELL
Payment of exercise price or tax liability
$12,830,026 $83.34 p/Share
153,948 Reduced 6.36%
2,266,453 Common stock, par valu...
Mar 27 2024
BUY
Grant, award, or other acquisition
-
221,667 Added 8.39%
2,420,401 Common stock, par valu...
Mar 01 2024
SELL
Payment of exercise price or tax liability
$13,875,094 $85.22 p/Share
162,815 Reduced 6.89%
2,198,734 Common stock, par valu...
Mar 01 2024
BUY
Grant, award, or other acquisition
-
221,667 Added 8.58%
2,361,549 Common stock, par valu...
Feb 09 2024
SELL
Open market or private sale
$1,345,500 $29.9 p/Share
45,000 Reduced 2.06%
2,139,882 Common stock, par valu...
Feb 08 2024
SELL
Open market or private sale
$7,265,133 $27.0 p/Share
269,079 Reduced 10.97%
2,184,882 Common stock, par valu...
Feb 08 2024
BUY
Exercise of conversion of derivative security
$555,892 $2.94 p/Share
189,079 Added 7.29%
2,404,882 Common stock, par valu...
Jan 31 2024
SELL
Open market or private sale
$2,099,500 $24.7 p/Share
85,000 Reduced 3.62%
2,264,882 Common stock, par valu...
Jan 31 2024
BUY
Exercise of conversion of derivative security
$104,550 $1.23 p/Share
85,000 Added 3.49%
2,349,882 Common stock, par valu...
Jan 30 2024
SELL
Open market or private sale
$838,250 $23.95 p/Share
35,000 Reduced 1.52%
2,264,882 Common stock, par valu...
Jan 30 2024
BUY
Exercise of conversion of derivative security
$43,050 $1.23 p/Share
35,000 Added 1.5%
2,299,882 Common stock, par valu...
Jan 04 2024
SELL
Payment of exercise price or tax liability
$734,876 $18.58 p/Share
39,552 Reduced 1.72%
2,264,882 Common stock, par valu...
Jan 03 2024
SELL
Payment of exercise price or tax liability
$3,734,735 $17.4 p/Share
214,640 Reduced 8.52%
2,304,434 Common stock, par valu...
Jan 03 2024
BUY
Grant, award, or other acquisition
-
310,000 Added 11.39%
2,410,549 Common stock, par valu...
May 01 2023
SELL
Open market or private sale
$1,010,250 $22.45 p/Share
45,000 Reduced 2.01%
2,197,963 Common stock, par valu...
Apr 19 2023
SELL
Open market or private sale
$750,750 $21.45 p/Share
35,000 Reduced 1.54%
2,242,963 Common stock, par valu...
Apr 17 2023
SELL
Open market or private sale
$3,169,750 $20.45 p/Share
155,000 Reduced 6.37%
2,277,963 Common stock, par valu...

Also insider at

SEEL
SEELOS THERAPEUTICS, INC. Healthcare
Director
BL

Brian Lian

President & CEO
San Diego, CA

Track Institutional and Insider Activities on VKTX

Follow Viking Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VKTX shares.

Notify only if

Insider Trading

Get notified when an Viking Therapeutics, Inc. insider buys or sells VKTX shares.

Notify only if

News

Receive news related to Viking Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VKTX